Trgovina Avalon GloboCare Corp. - AVCO CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | - | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | N/A |
Odpri* | N/A |
Enoletna sprememba* | N/A |
Dnevni razpon* | N/A |
Razpon 52 wk | 0.37-1.07 |
Povprečni obseg (10 dni) | 214.29K |
Povprečni obseg (3 meseci) | 4.05M |
Tržna kapitalizacija | 37.89M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 99.98M |
Prihodki | 1.24M |
EPS | -0.13 |
Dividenda (donosnost v %) | N/A |
Beta | 0.81 |
Datum naslednjega zaslužka | Mar 28, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|
Avalon GloboCare Corp. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 1.39097 | 1.37776 | 1.54631 | 1.56229 | 1.07755 |
Prihodki | 1.39097 | 1.37776 | 1.54631 | 1.56229 | 1.07755 |
Celotni stroški prihodkov | 0.97645 | 0.98756 | 1.20639 | 1.17427 | 0.82979 |
Bruto dobiček | 0.41452 | 0.3902 | 0.33992 | 0.38802 | 0.24776 |
Celotni odhodki iz poslovanja | 10.2248 | 13.8318 | 20.9235 | 9.19342 | 4.95541 |
Celotna prodaja/splošni/upravni stroški Odhodki | 6.82843 | 11.8901 | 16.8943 | 8.00077 | 2.79535 |
Depreciation / Amortization | 0.14124 | 0.14233 | 0.05819 | 0.01838 | 0.00894 |
Prihodki iz poslovanja | -8.83383 | -12.454 | -19.3772 | -7.63113 | -3.87786 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.26094 | -0.22043 | 2.16601 | -0.47023 | -0.19398 |
Čisti dobiček pred obdavčitvijo | -9.0905 | -12.6794 | -18.0702 | -8.0523 | -4.04965 |
Čisti dobiček po davkih | -9.0905 | -12.6794 | -18.0702 | -8.0523 | -4.04965 |
Čisti dobiček pred dodatnimi postavkami | -9.0905 | -12.6794 | -18.0702 | -7.77412 | -3.46429 |
Čisti dobiček | -9.0905 | -12.6794 | -18.0702 | -7.77412 | -3.46429 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -9.0905 | -12.6794 | -18.0702 | -7.77412 | -3.46429 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -9.0905 | -12.6794 | -18.0702 | -7.77412 | -3.46429 |
Popravljen čisti dobiček | -9.0905 | -12.6794 | -18.0702 | -7.77412 | -3.46429 |
Popravljene ponderirane povprečne delnice | 84.911 | 79.5081 | 75.1169 | 72.0041 | 65.0335 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.10706 | -0.15947 | -0.24056 | -0.10797 | -0.05327 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.09087 | -0.15947 | -0.22711 | -0.10797 | -0.03295 |
Nenavadni odhodki (prihodki) | 1.375 | 0 | 1.01001 | 0 | 1.32134 |
Drugo, neto | 0.00427 | -0.00498 | -0.85894 | 0.04908 | 0.0222 |
Manjšinski delež | 0 | 0 | 0 | 0.27817 | 0.58536 |
Raziskave in razvoj | 0.90369 | 0.81177 | 1.75462 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0.29763 | 0.3342 | 0.48676 | 0.28023 | 0.28977 |
Prihodki | 0.29763 | 0.3342 | 0.48676 | 0.28023 | 0.28977 |
Celotni stroški prihodkov | 0.21845 | 0.23635 | 0.31806 | 0.20515 | 0.21689 |
Bruto dobiček | 0.07918 | 0.09785 | 0.1687 | 0.07508 | 0.07288 |
Celotni odhodki iz poslovanja | 2.42457 | 2.59719 | 2.45174 | 2.58251 | 2.59336 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2.08944 | 2.01189 | 1.9096 | 2.13857 | 2.16328 |
Raziskave in razvoj | 0.11668 | 0.34896 | 0.22407 | 0.23879 | 0.21319 |
Prihodki iz poslovanja | -2.12694 | -2.26299 | -1.96498 | -2.30228 | -2.30359 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.05261 | -0.07128 | -0.06445 | -0.06155 | -0.06366 |
Drugo, neto | 0.10901 | 0.00002 | 0.0052 | -0.00108 | 0.00013 |
Čisti dobiček pred obdavčitvijo | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Čisti dobiček po davkih | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Manjšinski delež | 0 | 0 | 0 | 0 | 0 |
Čisti dobiček pred dodatnimi postavkami | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Čisti dobiček | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Popravljen čisti dobiček | -2.07054 | -2.33425 | -2.02422 | -2.36491 | -2.36712 |
Popravljene ponderirane povprečne delnice | 88.5024 | 86.2234 | 85.3624 | 84.6237 | 83.4131 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.0234 | -0.02707 | -0.02371 | -0.02795 | -0.02838 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.0234 | -0.02707 | -0.02371 | -0.02795 | -0.02838 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 1.32304 | 1.28634 | 1.5711 | 3.62543 | 3.23498 |
Denarna sredstva in kratkoročne naložbe | 0.80754 | 0.72658 | 0.76489 | 2.25229 | 3.02703 |
Cash | 0.80754 | 0.72658 | 0.76489 | 2.25229 | 3.02703 |
Celotne terjatve, neto | 0.09087 | 0.0354 | 0.24389 | 0.05222 | 0.04865 |
Accounts Receivable - Trade, Net | 0.03362 | 0.0354 | 0.24389 | 0.05222 | 0.04865 |
Prepaid Expenses | 0.23627 | 0.24462 | 0.47931 | 1.08438 | 0.11417 |
Other Current Assets, Total | 0.18837 | 0.27974 | 0.08301 | 0.22355 | 0.04246 |
Total Assets | 10.2422 | 10.3663 | 10.4905 | 13.3957 | 12.669 |
Property/Plant/Equipment, Total - Net | 8.03562 | 8.30213 | 8.33711 | 8.12944 | 7.67179 |
Property/Plant/Equipment, Total - Gross | 8.99685 | 9.15433 | 8.86106 | 8.4185 | 7.76825 |
Accumulated Depreciation, Total | -0.96123 | -0.8522 | -0.52396 | -0.28906 | -0.09646 |
Total Current Liabilities | 4.40166 | 2.59239 | 2.83546 | 1.14172 | 5.36018 |
Payable/Accrued | 1.67186 | 1.07927 | 1.14095 | 0.04509 | 0.03993 |
Accrued Expenses | 2.33979 | 1.44349 | 1.61627 | 0.81339 | 0.22102 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 1.5 |
Other Current Liabilities, Total | 0.06963 | 0.07824 | 0.27655 | 3.59921 | |
Total Liabilities | 7.15782 | 6.24935 | 6.02546 | 1.27952 | 4.77479 |
Total Long Term Debt | 2.75026 | 3.59 | 3.19 | 1 | 0 |
Total Equity | 3.0844 | 4.11692 | 4.46507 | 12.1162 | 7.89424 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.0089 | 0.00828 | 0.00767 | 0.00738 | 0.00703 |
Additional Paid-In Capital | 54.8886 | 46.8564 | 34.593 | 24.1534 | 11.4903 |
Retained Earnings (Accumulated Deficit) | -51.1253 | -42.0348 | -29.3554 | -11.2852 | -3.51108 |
Other Equity, Total | -0.16527 | -0.19051 | -0.25775 | -0.23686 | -0.09199 |
Total Liabilities & Shareholders’ Equity | 10.2422 | 10.3663 | 10.4905 | 13.3957 | 12.669 |
Total Common Shares Outstanding | 88.4552 | 82.2753 | 76.2108 | 73.3108 | 70.2786 |
Total Inventory | 0.01299 | 0.00267 | |||
Goodwill, Net | 0 | -0.92377 | |||
Intangibles, Net | 0 | 1.25569 | 2.50703 | ||
Other Long Term Assets, Total | 0.20471 | 0.1442 | 0 | 0.17901 | |
Accounts Payable | 0.0067 | 0.00003 | |||
Minority Interest | 0 | 0 | 0 | -0.8622 | -0.58539 |
Long Term Investments | 0.51563 | 0.52176 | 0.4831 | 0.38516 | |
Long Term Debt | 2.75026 | 3.59 | 3.19 | 1 | |
Treasury Stock - Common | -0.5225 | -0.5225 | -0.5225 | -0.5225 | |
Note Receivable - Long Term | 0.16321 | 0.11184 | 0.09924 | ||
Other Liabilities, Total | 0.0059 | 0.06695 | |||
Current Port. of LT Debt/Capital Leases | 0.39 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 0.91352 | 1.32304 | 1.25793 | 1.32533 | 2.16418 |
Denarna sredstva in kratkoročne naložbe | 0.52629 | 0.80754 | 0.53225 | 0.6853 | 1.69254 |
Cash | 0.52629 | 0.80754 | 0.53225 | 0.6853 | 1.69254 |
Celotne terjatve, neto | 0.11071 | 0.09087 | 0.09331 | 0.05533 | 0.06541 |
Accounts Receivable - Trade, Net | 0.04407 | 0.03362 | 0.04707 | 0.02365 | 0.02347 |
Prepaid Expenses | 0.07461 | 0.23627 | 0.38841 | 0.35031 | 0.20912 |
Other Current Assets, Total | 0.20191 | 0.18837 | 0.24396 | 0.23439 | 0.19711 |
Total Assets | 9.66868 | 10.2422 | 10.3938 | 10.3778 | 11.2852 |
Property/Plant/Equipment, Total - Net | 7.91903 | 8.03562 | 8.14861 | 8.26656 | 8.32664 |
Long Term Investments | 0.50399 | 0.51563 | 0.52057 | 0.53395 | 0.5322 |
Note Receivable - Long Term | 0.15527 | 0.16321 | 0.15748 | 0.10656 | 0.10917 |
Other Long Term Assets, Total | 0.17687 | 0.20471 | 0.30917 | 0.14546 | 0.15302 |
Total Current Liabilities | 5.14789 | 4.40166 | 4.53588 | 3.68013 | 3.22379 |
Payable/Accrued | 1.97682 | 1.67186 | 1.48934 | 1.27775 | 1.09006 |
Accrued Expenses | 3.17107 | 2.33979 | 2.65654 | 2.01238 | 1.74373 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.39 | 0.39 | 0.39 | 0.39 |
Total Liabilities | 8.38815 | 7.15782 | 8.54012 | 7.14912 | 6.63837 |
Total Long Term Debt | 3.24026 | 2.75026 | 3.96319 | 3.39319 | 3.30525 |
Long Term Debt | 3.24026 | 2.75026 | 3.96319 | 3.39319 | 3.30525 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0 | 0.0059 | 0.04106 | 0.0758 | 0.10934 |
Total Equity | 1.28053 | 3.0844 | 1.85363 | 3.22873 | 4.64684 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.00892 | 0.0089 | 0.00861 | 0.00856 | 0.00849 |
Additional Paid-In Capital | 55.1532 | 54.8886 | 51.3357 | 50.6879 | 49.756 |
Retained Earnings (Accumulated Deficit) | -53.1958 | -51.1253 | -48.791 | -46.7668 | -44.4019 |
Treasury Stock - Common | -0.5225 | -0.5225 | -0.5225 | -0.5225 | -0.5225 |
Other Equity, Total | -0.16325 | -0.16527 | -0.17716 | -0.17845 | -0.19323 |
Total Liabilities & Shareholders’ Equity | 9.66868 | 10.2422 | 10.3938 | 10.3778 | 11.2852 |
Total Common Shares Outstanding | 88.6258 | 88.4552 | 85.5324 | 85.0809 | 84.4236 |
Property/Plant/Equipment, Total - Gross | 8.99685 | ||||
Accumulated Depreciation, Total | -0.96123 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -9.0905 | -12.6794 | -18.0702 | -8.0523 | -4.04965 |
Denarna sredstva iz poslovanja | -5.02448 | -7.5461 | -7.07987 | -4.39602 | -1.33969 |
Denarna sredstva iz poslovanja | 0.31176 | 0.31478 | 0.50674 | 0.52284 | 0.18164 |
Nedenarne postavke | 2.2545 | 5.67477 | 8.84566 | 3.14595 | 2.28408 |
Cash Taxes Paid | 0 | 0 | 0.02156 | ||
Denarna sredstva Plačane obresti | 0 | 0.05 | 0.10906 | 0.37742 | 0 |
Spremembe v obratnem kapitalu | 1.49976 | -0.85621 | 1.63789 | -0.01251 | 0.24424 |
Denarna sredstva pri naložbenju | -0.06814 | -0.16919 | -0.55297 | -1.30781 | -8.01445 |
Kapitalski izdatki | -0.02783 | -0.11121 | -0.39378 | -0.85465 | -8.08648 |
Celotne druge postavke denarnih tokov pri naložbenju | -0.0403 | -0.05797 | -0.15919 | -0.45316 | 0.07203 |
Denarna sredstva pri financiranju | 5.17013 | 7.66428 | 6.15491 | 5.04222 | 9.50223 |
Postavke denarnega toka pri financiranju | -0.24043 | -0.53982 | -0.90883 | -0.4863 | -0.14778 |
Izdaja (odplačilo) delnic, neto | 2.8603 | 7.8041 | 6.27374 | 6.02851 | 8.15 |
Učinki deviznih tečajev | 0.00344 | 0.01269 | -0.00947 | -0.11313 | -0.00724 |
Neto sprememba denarnih sredstev | 0.08096 | -0.03831 | -1.4874 | -0.77475 | 0.14084 |
Izdaja (odplačilo) dolga, neto | 2.55026 | 0.4 | 0.79 | -0.5 | 1.5 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -2.07054 | -9.0905 | -6.75625 | -4.73203 | -2.36712 |
Cash From Operating Activities | -0.51121 | -5.02448 | -3.30752 | -2.59355 | -1.51553 |
Cash From Operating Activities | 0.08498 | 0.31176 | 0.22674 | 0.14129 | 0.07888 |
Non-Cash Items | 0.65725 | 2.2545 | 1.71006 | 1.18567 | 0.62097 |
Changes in Working Capital | 0.81709 | 1.49976 | 1.51193 | 0.81153 | 0.15175 |
Cash From Investing Activities | -0.00175 | -0.06814 | -0.06796 | -0.05051 | -0.03084 |
Other Investing Cash Flow Items, Total | 0 | -0.0403 | -0.04018 | -0.04018 | -0.03084 |
Cash From Financing Activities | 0.2315 | 5.17013 | 3.17834 | 2.60015 | 2.51221 |
Financing Cash Flow Items | -0.00407 | -0.24043 | -0.10356 | -0.07444 | -0.07444 |
Issuance (Retirement) of Stock, Net | 0.13557 | 2.8603 | 2.51871 | 2.48141 | 2.48141 |
Issuance (Retirement) of Debt, Net | 0.1 | 2.55026 | 0.76319 | 0.19319 | 0.10525 |
Foreign Exchange Effects | 0.00021 | 0.00344 | 0.00282 | 0.00264 | 0.00012 |
Net Change in Cash | -0.28125 | 0.08096 | -0.19433 | -0.04127 | 0.96596 |
Capital Expenditures | -0.00175 | -0.02783 | -0.02778 | -0.01033 | |
Cash Interest Paid | 0 | 0 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Avalon GloboCare Corp. Company profile
O družbi Avalon GloboCare Corp.
Avalon GloboCare Corp. je vertikalno integrirano podjetje v klinični fazi, ki se ukvarja z razvojem celičnih tehnologij. Družba se osredotoča na področja celične imunoterapije, vključno s CAR-T/NK, tehnologijo eksosomov (ACTEX) ter s COVID-19 povezanimi cepivi in terapevtiki prek svojih podružnic. Deluje v dveh poslovnih segmentih: segmentu poslovanja z nepremičninami in segmentu svetovalnih storitev, povezanih z medicino. Družba zagotavlja tudi storitve strateškega svetovanja in zunanjega izvajanja, da bi svojim strankam olajšala in izboljšala rast in razvoj ter konkurenčnost na trgih zdravstva in industrije CellTech. Njegovo medicinsko ekipo in objekt na nižji stopnji sestavljajo povezane mreže bolnišnic in strokovnjaki, specializirani za hematologijo, onkologijo, celično imunoterapijo, presaditev krvotvornih matičnih/progenitornih celic ter regenerativno terapijo. Njegovi klinični programi vključujejo AVA-001, ACTEX, FLASH-CAR in AVA-Trap.
Industry: | Biotechnology & Medical Research (NEC) |
4400 Route 9
Suite 3100
07728
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com